Show simple item record

dc.contributor.authorGuerrini, M.
dc.contributor.authorBeccati, D.
dc.contributor.authorShriver, Z.
dc.contributor.authorNaggi, A.M.
dc.contributor.authorBisio, A.
dc.contributor.authorCapila, I.
dc.contributor.authorLansing, J.
dc.contributor.authorGuglieri, S.
dc.contributor.authorFraser, B.
dc.contributor.authorAl-Hakim, A.
dc.contributor.authorGunay, S.
dc.contributor.authorViswanathan, K.
dc.contributor.authorZhang, Z.
dc.contributor.authorRobinson, L.
dc.contributor.authorVenkataraman, G.
dc.contributor.authorBuhse, L.
dc.contributor.authorNasr, M.
dc.contributor.authorWoodcock, J.
dc.contributor.authorLanger, R.
dc.contributor.authorLinhardt, Robert J.
dc.contributor.authorCasu, B.
dc.contributor.authorTorri, G.
dc.contributor.authorSasisekharan, R.
dc.date2008
dc.date.accessioned2022-06-23T04:01:57Z
dc.date.available2022-06-23T04:01:57Z
dc.date.issued2008
dc.identifier.citationOversulfated Chondroitin Sulfate is a major contaminant in Heparin associated with Adverse Clinical Events, M. Guerrini, D. Beccati, Z. Shriver, A. M. Naggi, A. Bisio, I. Capila, J. Lansing, S. Guglieri, B. Fraser, A. Al-Hakim, S. Gunay, K. Viswanathan, Z. Zhang, L. Robinson, G. Venkataraman, L. Buhse, M. Nasr, J. Woodcock, R. Langer, R. Linhardt, B. Casu, G. Torri, R. Sasisekharan, Nature Biotechnology, 26, 669-775, 2008.
dc.identifier.urihttps://hdl.handle.net/20.500.13015/5238
dc.identifier.urihttps://doi.org/10.1038%2Fnbt1407
dc.descriptionNature Biotechnology, 26, 669-775
dc.descriptionNote : if this item contains full text it may be a preprint, author manuscript, or a Gold OA copy that permits redistribution with a license such as CC BY. The final version is available through the publisher’s platform.
dc.description.abstractRecently, certain lots of heparin have been associated with an acute, rapid onset of serious side effects indicative of an allergic-type reaction. To identify potential causes for this sudden rise in side effects, we examined lots of heparin that correlated with adverse events using orthogonal high-resolution analytical techniques. Through detailed structural analysis, the contaminant was found to contain a disaccharide repeat unit of glucuronic acid linked beta1-->3 to a beta-N-acetylgalactosamine. The disaccharide unit has an unusual sulfation pattern and is sulfated at the 2-O and 3-O positions of the glucuronic acid as well as at the 4-O and 6-O positions of the galactosamine. Given the nature of this contaminant, traditional screening tests cannot differentiate between affected and unaffected lots. Our analysis suggests effective screening methods that can be used to determine whether or not heparin lots contain the contaminant reported here.
dc.languageen_US
dc.language.isoENG
dc.publisherNature
dc.relation.ispartofThe Linhardt Research Labs Online Collection
dc.relation.ispartofRensselaer Polytechnic Institute, Troy, NY
dc.relation.urihttps://harc.rpi.edu/
dc.subjectBiology
dc.subjectChemistry and chemical biology
dc.subjectChemical and biological engineering
dc.subjectBiomedical engineering
dc.titleOversulfated Chondroitin Sulfate is a major contaminant in Heparin associated with Adverse Clinical Events
dc.typeArticle
dcterms.accessRightsA full text version is available in DSpace@RPI
dcterms.isVersionOfhttps://doi.org/10.1038%2Fnbt1407
dc.rights.holderIn Copyright : this Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). https://rightsstatements.org/page/InC/1.0/
dc.creator.identifierhttps://orcid.org/0000-0003-2219-5833
dc.relation.departmentThe Linhardt Research Labs.
dc.relation.departmentThe Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record